Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Affymetrix commences shipment of gene profiling reagents

Affymetrix, Inc. today began shipping its FDA-cleared Gene Profiling Reagents. Affymetrix also announced the availability of the new Gene Profiling Array cGMP U133 P2, a version of the widely cited Human Genome U133 Plus 2.0 Array, as another component to its GeneChip Instrument System, which is used by Affymetrix partners for assay development.

12 Jul 2011

Gilead announces expansion of global access program for HIV medications

Gilead Sciences, Inc. announced today an expansion of its global access program in an effort to provide accelerated access to Gilead medicines for the treatment of HIV/AIDS.

12 Jul 2011

Novis opens fifth office location in San Luis Obispo

Novis Pharmaceuticals, a leading distributor of critical care products, has officially opened their fifth office location in San Luis Obispo, California. With more than 30 years of industry experience, Novis' aggressive plan to expand their national presence continues to move forward with news of this location opening. Placed strategically between San Francisco and Los Angeles, Novis believes this will help capture parts of the regional market.

11 Jul 2011

Sanofi announces strategic divestiture of dermatology business to Valeant

Sanofi announced today the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc., for a total cash consideration of US $425 million. Valeant is a pharmaceutical company focused on the neurology and dermatology therapeutic areas, based in Mississauga, Ontario, Canada.

11 Jul 2011

USANA receives FDA registration to manufacture OTC drugs

USANA Health Sciences, Inc. today announced it has obtained the U.S. Food and Drug Administration's "Drug Establishment Registration," allowing the company to manufacture over-the-counter (OTC) drugs and holding it to a standard well above what is required of a dietary supplement manufacturer.

11 Jul 2011

Ion Torrent ships three next-generation sequencers

Ion Torrent, a unit of Life Technologies Corporation, today announced that it is shipping its new 100 Mb Ion 316 chip, which has tenfold more throughput than the original Ion 314 chip, and that its 1 Gb Ion 318 chip will be available in the fourth quarter.

11 Jul 2011

Nevada District Court rules in favor of PDL over Genentech, Roche lawsuit

PDL BioPharma, Inc. (PDL) announced a favorable ruling today, specifically, that on July 7, 2011, the Second Judicial District Court of Nevada ruled in favor of PDL on two motions to dismiss filed by Genentech and F. Hoffmann LaRoche, Ltd. in PDL's lawsuit related to the 2003 settlement agreement with Genentech.

11 Jul 2011

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced an exclusive licensing agreement for Watson to commercialize Antares' topical oxybutynin gel product in the U.S. and Canada.

11 Jul 2011

Amgen, Micromet to expand development of BiTE antibodies against solid tumors

Micromet, Inc. announced today that it has entered into a collaboration agreement with Amgen Inc. for the research of BiTE antibodies against three undisclosed solid tumor targets.

11 Jul 2011

Valeant signs agreement to acquire Dermik

Valeant Pharmaceuticals International, Inc. announced today that Valeant and its subsidiary, Valeant International SRL, have signed an agreement to acquire Dermik, a dermatology unit of Sanofi in the U.S. and Canada, as well as the worldwide rights to Sculptra Aesthetic.

11 Jul 2011

Corporates profit from pinkwashing

Companies that try to increase sales of their products by adopting the color pink and pink ribbons to imply that they support breast cancer research-a practice called pinkwashing-but at the same time permit the use of chemicals shown to cause cancer are committing a form of social injustice against women, according to a thought-provoking article in Environmental Justice.

8 Jul 2011

Roche, CPRIT partner to advance cancer research projects in Texas

The Cancer Prevention and Research Institute of Texas (CPRIT) today announced a strategic partnership agreement with the Swiss-based healthcare company Roche to accelerate the development of promising oncology-related cancer research projects in Texas.

8 Jul 2011

Low temperature vacuum drying process for production of probiotics

Probiotic bacteria are rapidly gaining ground as healthy food supplements. However, the production of this "functional food" has its pitfalls: only few probiotic bacterial strains are robust enough to survive conventional production processes.

7 Jul 2011

Spiking Neural Network architecture aims to map out brain's individual functions

University of Manchester scientists have taken a key step towards producing a high-performance computer which aims to create working models of human brain functions.

7 Jul 2011

New technology can inexpensively render medical linens, clothing permanently germ-free

A University of Georgia researcher has invented a new technology that can inexpensively render medical linens and clothing, face masks, paper towels-and yes, even diapers, intimate apparel and athletic wear, including smelly socks-permanently germ-free.

6 Jul 2011

New technologies could bring innovative sensors, devices for 'lab-on-a-chip' applications

Researchers are developing new technologies that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses and DNA for a range of potential applications, from drug manufacturing to food safety.

6 Jul 2011

Drug companies' desires to maintain status quo are 'lethal'

In the second of a two-part Al Jazeera opinion piece series "examining the methods by which multinational drug corporations inflate their expenses and justify their pricing strategies," Khadija Sharife, a journalist and visiting scholar at the Center for Civil Society, looks at U.S. tax laws, lax oversight of international clinical trials, the cost of research on new pharmaceutical compounds, and vaccine manufacturing.

6 Jul 2011

Viewpoints: Medical docs begin residency, best practices, Kansas abortions

Today, after four arduous years of examinations, graduating medical doctors will report to their residency programs. Armed with stethoscopes and scalpels, they're preparing to lead the charge against disease in its ravaging, chimerical forms. They carry with them the classic tomes: Harrison's Principles of Internal Medicine and Gray's Anatomy. But I have an unlikely addition for their mental rucksacks: "Grimm's Fairy Tales".

2 Jul 2011

Panel advises FDA to reject Avastin as breast cancer drug

The unanimous recommendation by this committee of cancer experts increases the likelihood that the drug will no longer be widely available for the treatment of breast cancer. Avastin, however, will continue to have the Food and Drug Adminstration's approval for use in treating certain other cancers.

1 Jul 2011